Rare & Genetic Diseases
| 10 min read
People with achromatopsia have never seen color. Restorative gene therapies have had mixed success, leaving researchers wondering why.
| 5 min read
The durability and capacity to boost protein expression of circular RNA makes it a promising candidate for next-generation vaccines and gene therapies.
Spatial transcriptomics technologies unveil a goldmine of biological information.
| 1 min read
Cutting-edge DNA synthesis technology propels scientific advancements and drug discoveries forward at unprecedented speeds.
| 3 min read
By watching brain organoids develop, researchers observed surprising abnormalities caused by mutations in a gene related to early-onset Alzheimer’s disease.
| 4 min read
A gene therapy targeting excitatory neurons significantly reduced seizures in a mouse model of the most common cause of child epilepsy.
Biobanking gives scientists access to thousands of biological samples, moving
precision medicine one step closer to reality.
| 8 min read
Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
Gene therapy has a complicated history, marked by many ups and downs and crafted by ever-advancing technologies.
| 10+ min read
Scientists identified specific genes that confer protection or vulnerability to various infections, pointing the way to new treatments.
| 6 min read
Experts discussed the major hurdles of AAV gene therapy, including immunogenicity, vector design, and AAV variability.
